Insider Transactions in Q3 2022 at Entrada Therapeutics, Inc. (TRDA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 17
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.48%
|
$200
$2.1 P/Share
|
|
Aug 16
2022
|
Kory James Wentworth Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
200
-0.97%
|
$2,600
$13.0 P/Share
|
|
Aug 16
2022
|
Kory James Wentworth Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.48%
|
$200
$2.1 P/Share
|
|
Jul 27
2022
|
Dipal Doshi CEO |
SELL
Open market or private sale
|
Direct |
2,000
-0.95%
|
$24,000
$12.0 P/Share
|